TIFFANY NGUYEN: Open Payments
NPI 1790111607 · CAMP PENDLETON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 9 payments from 6 companies in 2025. Trend: 2023 $66 · 2024 $65 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $87 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
Products named: AREXVY, FUROSCIX, BEXSERO, JARDIANCE, EVENITY, PAXLOVID, TZIELD.
Industry payments across CA — which companies pay providers there.
